BSE filing, NSE: VINEETLAB. Summary written from the filing by ALFA Finder's alert engine.
Vineet Laboratories Ltd: key numbers
- Share price
- ₹36.81
- Market cap
- ₹70.70 Cr
- Revenue (annual)
- ₹59.40 Cr
- Net profit (annual)
- ₹1.11 Cr
- P/E (TTM)
- 20.2×Sector 46.1×
- Promoter holding
- 5.98%+0.00% QoQ
- FII holding
- 0.24%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vineet Laboratories Ltd
All →Vineet Laboratories Q1 FY27 Results: Turns Profitable, Net Profit ₹1.5 Cr
Vineet Laboratories Ltd reported revenue from operations of ₹10.4 Cr (+40.5% YoY) and net profit of ₹1.5 Cr for Q1 FY27.
- Key figure
- Net profit ₹1.5 Cr
Vineet Laboratories Board Meeting Date
Vineet Laboratories Limited has scheduled a board meeting on October 26, 2026, to consider and approve standalone financial results for the quarter ended June 30, 2026.
Vineet Laboratories Management Change
Mr. Vennapusa Premanand Reddy has resigned as a Director of Vineet Laboratories Limited, effective October 14, 2026.
Vineet Laboratories Management Change
Vineet Laboratories Limited announced the resignation of M/s. NSVR & Associates LLP as its statutory auditor, effective September 29, 2026. The company will appoint a successor.
Vineet Laboratories Other Announcement
Vineet Laboratories received an extension from the Registrar of Companies, Hyderabad, to hold its 10th Annual General Meeting by 30th November 2026.
Vineet Laboratories Q4 FY26 Results: Turns Profitable, Net Profit ₹0.7 Cr
Vineet Laboratories Ltd reported revenue from operations of ₹18.9 Cr (+34.0% YoY) and net profit of ₹0.7 Cr for Q4 FY26.
- Key figure
- Net profit ₹0.7 Cr
Other other announcement announcements
All →Milky Mist Dairy Food Other Announcement
Milky Mist's board appointed B Chandra & Associates as Secretarial Auditors for FY 2026-27 to 2030-31. Shareholder approval is pending at the ensuing AGM.
- Execution
- FY 2026-27 to FY 2030-31 (five years)
Mahamaya Lifesciences Other Announcement
Mahamaya Lifesciences Ltd, an SME-platform listed company, confirms non-applicability of Corporate Governance under Regulation 27(2) for the quarter ended 30 September 2026. A Company Secretary certificate is enclosed.
Wipro Other Announcement
Wipro disclosed a designated person's 34,200-share ADR sale worth about ₹0.67 Crore on 28 October 2026. The sale followed RSU exercise, leaving 60,266 securities held.
- Value
- ₹0.67 Cr
OK Play India Other Announcement
OK Play India filed its quarterly shareholding pattern for the quarter ended September 2026. It shows category holdings only, with no transaction.
Spice Islands Industries Other Announcement
Spice Islands Industries filed a Reg 32 statement reporting no deviation in preferential issue fund utilization for Q3 FY27. The ₹8.70 Crore raise is fully deployed.
Setubandhan Infrastructure Other Announcement
RP informs exchanges that Setubandhan Infrastructure cannot file quarterly compliance documents due to depository fee non-payment. The company remains under CIRP with a pending NCLAT appeal.